As the federal and state governments focus their attention on malaria, TB, and HIV control, thousands of Nigerians, including children under five, die needlessly every year from preventable diseases ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV ...

Pritelivir demonstrated numerically improved efficacy relative to foscarnet, and a more favourable safety and tolerability ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

One in 10 clinics in SA — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab ...

As part of Joy FM’s Cancer Awareness Month campaign, Obstetrician-Gynecologist Professor Samuel Antwi Oppong has urged women ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

One in 10 clinics in South Africa—across 22 health districts in six provinces—could start to hand out a twice-a-year anti-HIV jab as early as ...

The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October ...

The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...